PR07, NCIC PR.3: A Randomised Trial of Hormone Therapy Plus Radical Radiotherapy Versus Hormone Therapy Alone in Non-Metastatic Prostate Cancer
What is this study about?
The PR07 trial was conducted as a collaboration between the MRC CTU and the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). The trial closed to recruitment in 2005 with over 1200 patients; patients remain on follow up. The aim of the trial was to evaluate whether there was a benefit from the addition of external beam radiation therapy to the treatment of patients with non-metastatic prostate cancer who have not had a radical prostatectomy and are receiving hormonal therapy.
Who is included?
Men with non-metastatic prostate cancer
When is it taking place?
Patients were recruited from 1995 in Canada and 1999 in the UK; recruitment closed in 2005
Where is it taking place?
Hospitals throughout the UK and Canada
Who is funding the study?
Medical Research Council
Contact details
Further Information
| Type of study: | Randomised trial |
| MAMS | This is a multi arm multi stage study |
| Status: | Closed |
| Also included in this study: | Health Economics
Quality of life outcomes
Consumer involvement
NHS Information Centre flagging |
| Registration numbers: | Registered with the number ISRCTN24991896 |
Back to the top of page
